GEP20146006B - Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3- dimethyl-butyramide - Google Patents

Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3- dimethyl-butyramide

Info

Publication number
GEP20146006B
GEP20146006B GEAP201012498A GEAP2010012498A GEP20146006B GE P20146006 B GEP20146006 B GE P20146006B GE AP201012498 A GEAP201012498 A GE AP201012498A GE AP2010012498 A GEAP2010012498 A GE AP2010012498A GE P20146006 B GEP20146006 B GE P20146006B
Authority
GE
Georgia
Prior art keywords
dimethyl
butyramide
phenyl
morpholin
stable forms
Prior art date
Application number
GEAP201012498A
Inventor
De Diego Heidi Lopez
Karin Liltorp
Svend Treppendahl
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42237259&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GEP20146006(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of GEP20146006B publication Critical patent/GEP20146006B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

An invention relates to N-(2,6-dimethyl-4-morp¬holin-4-yl-phenyl)-3,3-dimethyl-butyramide and preparation method thereof.
GEAP201012498A 2009-05-11 2010-05-11 Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3- dimethyl-butyramide GEP20146006B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200900597 2009-05-11

Publications (1)

Publication Number Publication Date
GEP20146006B true GEP20146006B (en) 2014-01-10

Family

ID=42237259

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP201012498A GEP20146006B (en) 2009-05-11 2010-05-11 Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3- dimethyl-butyramide

Country Status (23)

Country Link
EP (1) EP2430008A2 (en)
JP (1) JP2012526152A (en)
KR (1) KR20120022934A (en)
CN (1) CN102459208A (en)
AR (1) AR076556A1 (en)
AU (1) AU2010246724B2 (en)
BR (1) BRPI1013930A2 (en)
CA (1) CA2761383A1 (en)
CL (1) CL2011002814A1 (en)
CO (1) CO6460741A2 (en)
CR (1) CR20110590A (en)
DO (1) DOP2011000351A (en)
EA (1) EA201171381A1 (en)
GE (1) GEP20146006B (en)
IL (1) IL216148A0 (en)
MA (1) MA33351B1 (en)
MX (1) MX2011011885A (en)
NZ (1) NZ596738A (en)
SG (1) SG175968A1 (en)
TN (1) TN2011000557A1 (en)
TW (1) TW201041857A (en)
WO (1) WO2010130260A2 (en)
ZA (1) ZA201108112B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI349666B (en) * 2004-03-12 2011-10-01 Lundbeck & Co As H Substituted morpholine and thiomorpholine derivatives
JP5419691B2 (en) * 2006-08-23 2014-02-19 バレアント ファーマシューティカルズ インターナショナル Derivatives of 4- (N-azacycloalkyl) anilide as potassium channel modulators
JP2011513196A (en) * 2007-08-01 2011-04-28 ハー・ルンドベック・アクチエゼルスカベット Use of a KCNQ potassium channel opener to alleviate symptoms of or treat a disorder or condition in which the dopaminergic system is disrupted

Also Published As

Publication number Publication date
ZA201108112B (en) 2013-01-30
TW201041857A (en) 2010-12-01
BRPI1013930A2 (en) 2019-09-24
MX2011011885A (en) 2011-12-06
CL2011002814A1 (en) 2012-04-13
TN2011000557A1 (en) 2013-05-24
DOP2011000351A (en) 2012-01-31
MA33351B1 (en) 2012-06-01
JP2012526152A (en) 2012-10-25
SG175968A1 (en) 2011-12-29
WO2010130260A3 (en) 2011-06-16
EP2430008A2 (en) 2012-03-21
WO2010130260A9 (en) 2012-10-18
CA2761383A1 (en) 2010-11-18
IL216148A0 (en) 2012-01-31
CR20110590A (en) 2012-02-22
EA201171381A1 (en) 2012-05-30
WO2010130260A2 (en) 2010-11-18
CO6460741A2 (en) 2012-06-15
AR076556A1 (en) 2011-06-22
AU2010246724A1 (en) 2011-12-08
AU2010246724B2 (en) 2013-03-21
CN102459208A (en) 2012-05-16
NZ596738A (en) 2013-04-26
KR20120022934A (en) 2012-03-12

Similar Documents

Publication Publication Date Title
HK1194071A1 (en) Certain triazolopyrazines, compositions thereof and methods of use therefor
MX338884B (en) Compositions and methods comprising protease variants.
MX339878B (en) Novel solid forms of bendamustine hydrochloride.
EP2248171A4 (en) Semiconductor constructions, and methods of forming semiconductor constructions
EP2437602A4 (en) Ophthalmic formulations, methods of manufacture, and methods of using same
GEP20146114B (en) New crystalline form vi of agomelatine, preparation method and application thereof
HK1173469A1 (en) Scaffolds formed from polymer-protein conjugates, methods of generating same and uses thereof
MY152437A (en) Oral care compositions
MX2011010012A (en) Novel anti-î+-5î²1 antibodies and uses thereof.
EP2041323A4 (en) Virosomes, methods of preparation, and immunogenic compositions
EP2638096A4 (en) Polyketal adducts, methods of manufacture and uses thereof
HK1184181A1 (en) POLYETHERAMINES, COMPOSITIONS INCLUDING POLYETHERAMINES, AND METHODS OF g MAKING
WO2011086584A3 (en) Improved process for the preparation of amide intermediates and their use thereof
MY161868A (en) Anti-bv8 antibodies and uses thereof
EP2442826A4 (en) Influenza vaccine, composition, and methods of use
HK1167240A1 (en) Compositions, synthesis, and methods of utilizing arylpiperazine derivatives
BRPI0920995A2 (en) charged metal catalyst and method of preparation thereof.
EP2447365A4 (en) Cell-free protein synthesis solution, cell-free protein synthesis kit, and protein synthesis method
MX361692B (en) Fatty acid amide hydrolase inhibitors.
EP2445873A4 (en) Protease inhibitors, compositions and methods of use
GB2488494B (en) Solution, use and method of preparation thereof
WO2010111421A3 (en) Isoform nell-1 peptide
GEP20146006B (en) Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3- dimethyl-butyramide
GEP20207101B (en) ENANTIO- AND STEREO-SPECIFIC SYNTHESES OF β-AMINO-α- HYDROXY AMIDES
EP2279221A4 (en) Organo-neutralized diatomaceous earth, methods of preparation, and uses thereof